← Eichor
Condition: Prevention Of Venous Thromboembolism Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Prevention Of Venous Thromboembolism

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Excretion of Rivaroxaban in Human Breast Milk
Phase 1 · 1 location(s) · Thomas Jefferson University · NCT06831474VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Phase 2/Phase 3 · 1 location(s) · Ottawa Hospital Research Institute · NCT05920343Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
Phase 4 · 1 location(s) · Ottawa Hospital Research Institute · NCT06603870DOAC - Dosing Options in AntiCoagulation Prophylaxis
Phase 3 · 1 location(s) · University of Vermont · NCT07005024Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Phase 2/Phase 3 · 22 location(s) · Yale University · NCT04924322Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study
Phase N/A · 3 location(s) · University of Dublin, Trinity College · NCT07196020Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
Phase 3 · 1 location(s) · Arianna Anticoagulazione Foundation · NCT04257487REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip
Phase 3 · 32 location(s) · Regeneron Pharmaceuticals · NCT07213778Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic An
Phase 2 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT05089227Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Canc
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07493304Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Phase 2 · 1 location(s) · Livzon Pharmaceutical Group Inc. · NCT06963320Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
NA · 1 location(s) · Medical University of South Carolina · NCT06451003Evaluation of the SCALED (SCaling AcceptabLE cDs)
Phase N/A · 1 location(s) · University of Minnesota · NCT05628207Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eA
NA · 1 location(s) · Brigham and Women's Hospital · NCT03728166ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
Phase 3 · 6 location(s) · Prof. Stavros Konstantinides, MD · NCT06611319Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
NA · 1 location(s) · Pirogov Russian National Research Medical University · NCT06753786Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk
Phase 4 · 18 location(s) · University Hospital, Brest · NCT06845423Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients
Phase N/A · 1 location(s) · Xuanwu Hospital, Beijing · NCT06947707Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention
Phase 4 · 1 location(s) · Mayo Hospital Lahore · NCT07243080AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positiv
Phase 3 · 42 location(s) · University Hospital, Brest · NCT05198960Evaluating the Hemodynamic Performance of the VenAir Sequential Compression System
NA · 1 location(s) · Wellell Inc. Taiwan · NCT07287007Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
NA · 1 location(s) · Alexandria University · NCT06689241REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Phase 3 · 46 location(s) · Regeneron Pharmaceuticals · NCT07015905REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Phase 3 · 13 location(s) · Regeneron Pharmaceuticals · NCT07410117GEKO Venous Thromboembolism Prevention Study
NA · 18 location(s) · Firstkind Ltd · NCT05476913
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.